Adrian Van den Hoven
Adrian van den Hoven joined Medicines for Europe as a Director General in September 2013. His priorities are to foster better access to generic, biosimilar and value added medicines for patients, to stimulate competition in off-patent medicine markets and support sustainable pricing policies, to promote high regulatory standards while ensuring continued supply and access to medicines and to develop a coherent EU industrial strategy to support dynamic and competitive generic, biosimilar and value added medicines industries in Europe. Prior to joining Medicines for Europe, Adrian van den Hoven was Deputy-Director General of BUSINESSEUROPE where he was responsible for the International Relations department, covering trade negotiations and bilateral relations, and the Industry department, covering industrial, energy, environmental and research policy. He previously worked as an International Relations researcher in Italy (EUI), France (Nice) and Canada (Windsor).
Construction Industry 2026
AI in Business 2026
Portfolio Insurance 2026
25 years of Portfolio Conferences
The Portfolio Group's event division has been shaping the professional events market for over two decades, continuously in a market-leading position. We organize 60 business conferences and nearly 10 awards ceremonies nationwide each year, setting the direction in 9 industries: economy, agriculture, real estate, healthcare, finance, automotive, energy, IT, sustainability. We reach 40,000 participants annually. The name Portfolio Events is a guarantee of high-quality professional content and outstanding B2B and B2C networking – in premium hotels, exclusive environments, with business networking and lead generation opportunities. So far, more than 7,000 speakers and nearly 50,000 companies have participated in our events: experts, top executives, decision-makers, opinion leaders, owners. Join us and level up - we provide the top community of the domestic business sphere!